Guiyang Xintian Pharmaceutical Co Ltd (002873) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.039x

Based on the latest financial reports, Guiyang Xintian Pharmaceutical Co Ltd (002873) has a cash flow conversion efficiency ratio of 0.039x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥48.81 Million ≈ $7.14 Million USD) by net assets (CN¥1.26 Billion ≈ $184.86 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Guiyang Xintian Pharmaceutical Co Ltd (002873) total market value for the company's overall valuation and market capitalisation.

Guiyang Xintian Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Guiyang Xintian Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Guiyang Xintian Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Guiyang Xintian Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Explore Guiyang Xintian Pharmaceutical Co Ltd (002873) cash flow quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Valuetronics Holdings Limited F:GJ7	0.021x
Omni Bridgeway Ltd AU:OBL	-0.051x
Arbonia AG SW:ARBN	0.049x
Tangshan Jidong Equipment Engineering Co Ltd SHE:000856	-0.031x
China Western Power Industrial Co Ltd SHE:002630	0.072x
INTERGRATED DIA.H DL 025 F:8I8	0.096x
CompX International Inc NYSE MKT:CIX	0.087x
Yantai Yatong Precision Mechanical Corp. A SHG:603190	N/A

Annual Cash Flow Conversion Efficiency for Guiyang Xintian Pharmaceutical Co Ltd (2012–2025)

The table below shows the annual cash flow conversion efficiency of Guiyang Xintian Pharmaceutical Co Ltd from 2012 to 2025. View today's stock price for Guiyang Xintian Pharmaceutical Co Ltd for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥1.26 Billion ≈ $183.83 Million	CN¥83.73 Million ≈ $12.25 Million	0.067x	-9.64%
2024-12-31	CN¥1.19 Billion ≈ $174.82 Million	CN¥88.13 Million ≈ $12.90 Million	0.074x	+5.59%
2023-12-31	CN¥1.11 Billion ≈ $162.92 Million	CN¥77.78 Million ≈ $11.38 Million	0.070x	+4.05%
2022-12-31	CN¥1.13 Billion ≈ $165.24 Million	CN¥75.82 Million ≈ $11.09 Million	0.067x	-51.90%
2021-12-31	CN¥890.44 Million ≈ $130.30 Million	CN¥124.30 Million ≈ $18.19 Million	0.140x	-34.22%
2020-12-31	CN¥828.30 Million ≈ $121.21 Million	CN¥175.77 Million ≈ $25.72 Million	0.212x	+345.92%
2019-12-31	CN¥708.76 Million ≈ $103.71 Million	CN¥33.73 Million ≈ $4.94 Million	0.048x	-33.95%
2018-12-31	CN¥660.59 Million ≈ $96.66 Million	CN¥47.59 Million ≈ $6.96 Million	0.072x	-27.78%
2017-12-31	CN¥622.11 Million ≈ $91.03 Million	CN¥62.06 Million ≈ $9.08 Million	0.100x	-54.60%
2016-12-31	CN¥279.21 Million ≈ $40.86 Million	CN¥61.34 Million ≈ $8.98 Million	0.220x	+22.08%
2015-12-31	CN¥226.31 Million ≈ $33.12 Million	CN¥40.73 Million ≈ $5.96 Million	0.180x	-8.09%
2014-12-31	CN¥190.50 Million ≈ $27.88 Million	CN¥37.30 Million ≈ $5.46 Million	0.196x	+122.05%
2013-12-31	CN¥157.38 Million ≈ $23.03 Million	CN¥13.88 Million ≈ $2.03 Million	0.088x	-26.49%
2012-12-31	CN¥178.44 Million ≈ $26.11 Million	CN¥21.41 Million ≈ $3.13 Million	0.120x	--

About Guiyang Xintian Pharmaceutical Co Ltd

SHE:002873 China Biotechnology

Market Cap

$286.83 Million

CN¥1.96 Billion CNY

Market Cap Rank

#15157 Global

#4496 in China

Share Price

CN¥8.03

Change (1 day)

-0.86%

52-Week Range

CN¥7.16 - CN¥11.90

All Time High

CN¥103738.98